simeprevir Articles

US FDA grants priority review for Janssen's simeprevir, accepts Biogen Idec's Eloctate and Actavis' progestin-only patch filing

13 May 2013

Janssen files for European approval of hep C candidate simeprevir

25 April 2013

Highlights of presentations from Bristol-Myers, J&J, Gilead and AbbVie at EASL meeting

24 April 2013

Medivir/J&J, Merck & Co and Bristol-Myers to present at Int Liver Congress

9 April 2013

Janssen gains FDA approval of Invokana for type 2 diabetes; files simeprevir NDA

2 April 2013

Clinical updates at ROI meeting on GSK's dolutegravir and Medivir's simeprevir

7 March 2013

Vertex links with Janssen and GlaxoSmithKline for combo trials with its VX-135 for hepatitis C

2 November 2012

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end